MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Diagnostic utility of cerebrospinal fluid t-tau/p-tau181 in Parkinson’s disease with mild cognitive impairment: A cross-sectional study in Chinese cohort

P. Zhang, Y. Li, L.J Wang, Y.H Zhang (Guangzhou, China)

Meeting: MDS Virtual Congress 2020

Abstract Number: 454

Keywords: Cognitive dysfunction, Neurofibrillary tangles(NFT)

Category: Parkinson's Disease: Cognitive functions

Objective: This study explores the value of α-Syn, Aβ1-42, t-tau, p-tau181 in cerebrospinal fluid(CSF) and their ratios for the diagnosis of Parkinson’s disease with mild cognitive impairment (PD-MCI).

Background: There are no a biomarker distinguish PD-MCI from PD with normal cognition(PD-NC).

Method: Fifty-three patients with PD and twenty four healthy controls were recruited in the study. The clinical data were collected. According to the Level-II level in the diagnostic criteria for PD-MCI as published by MDS, all non-dementia PD patients were divided into PD-NC group (27 cases) and PD-MCI group (26 cases). ELISA method was used to detect the levels of biomarkers in CSF. We performed their correlation analysis with cognition and receiver operating characteristic (ROC) curve analysis to assess the diagnostic accuracy of the most discriminative indicators of disease status.

Results: This study found no differences in clinical data such as age, gender, education level, course of disease, H&Y stage, HAMA, HAMD among the three groups (P> 0.05). MMSE and MoCA scores of patients in the PD-MCI group were significantly lower than those in the PD-NC and HC groups (P <0.01) (see Table 1). There were no statistical differences in the distribution of Aβ1-42, P-tau181/Aβ1-42, t-tau/Aβ1-42, P-tau181/α-Syn (P> 0.05) among the three groups. α-Syn, α-Syn/Aβ1-42 were decreased significantly in PD-MCI compared with HC group (P <0.05); t-tau (P = 0.013), t-tau/P-tau181(P <0.001) in PD -MCI was significantly higher than PD-NC and HC; p-tau181 (P = 0.004), t-tau/α-Syn (P = 0.001) were significantly higher in PD-NC and PD-MCI than in HC group(see Table 2 and Figure 1). Further analysis found that the increase of t-tau/p-tau181 in PD patients was related to the decline in the block design scale score (P = 0.017) and logical memory scale score (P = 0.043) (see Table 3). It was found that the area under the ROC curve of t-tau protein to diagnose PD-MCI is 0.670 (P = 0.015), and the sensitivity and specificity is 69.2%, 56.9%,respectively. The t-tau/p-tau181 used to diagnose PD-MCI had an area under the ROC curve of 0.768 (P <0.001), the sensitivity and specificity is 80.8%, 68.6%, respectively (see Figure 2).

Conclusion: The t-tau/p-tau181 has a higher sensitivity and Specificity in identifying PD-MCI.

Table 1. Demographic and clinical characteristics in HC group, PD-NC group and PD-MCI group

Table 2. CSF biomarkers in HC group, PD-NC group and PD-MCI group

Table 3. Relationship between ratio of t-tau and P-tau181 in CSF and cognitive domain scores of PD

Figure 1. CSF biomarkers in HC group, PD-NC group and PD-MCI group

Figure 2. ROC curve of cerebrospinal fluid t-tau, ratio of tau and p-tau181 in the diagnosis of PD-MCI

To cite this abstract in AMA style:

P. Zhang, Y. Li, L.J Wang, Y.H Zhang. Diagnostic utility of cerebrospinal fluid t-tau/p-tau181 in Parkinson’s disease with mild cognitive impairment: A cross-sectional study in Chinese cohort [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/diagnostic-utility-of-cerebrospinal-fluid-t-tau-p-tau181-in-parkinsons-disease-with-mild-cognitive-impairment-a-cross-sectional-study-in-chinese-cohort/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/diagnostic-utility-of-cerebrospinal-fluid-t-tau-p-tau181-in-parkinsons-disease-with-mild-cognitive-impairment-a-cross-sectional-study-in-chinese-cohort/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley